Found: 31
Select item for more details and to access through your institution.
The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 4, p. n/a, doi. 10.1002/prp2.157
- By:
- Publication type:
- Article
The Stereoselective Sulfate Conjugation of 4′-Methoxyfenoterol Stereoisomers by Sulfotransferase Enzymes.
- Published in:
- Chirality, 2012, v. 24, n. 10, p. 796, doi. 10.1002/chir.22072
- By:
- Publication type:
- Article
Immunomodulatory effect of Myrtenol on benzo (a) pyrene‐induced lung cancer in Swiss albino mice via modulation of tumor markers, cytokines and inhibition of PCNA expression.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 1, p. 1, doi. 10.1002/jbt.23578
- By:
- Publication type:
- Article
Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 10, p. 1, doi. 10.1371/journal.pgen.1004648
- By:
- Publication type:
- Article
Optimization and validation of a capillary electrophoresis laser-induced fluorescence method for amino acids determination in human plasma: Application to bipolar disorder study.
- Published in:
- Electrophoresis, 2013, v. 34, n. 11, p. 1701, doi. 10.1002/elps.201200632
- By:
- Publication type:
- Article
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Statin Drug‐Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical Resources.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 6, p. 704, doi. 10.1002/jcph.2406
- By:
- Publication type:
- Article
Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S10, doi. 10.1002/jcph.2327
- By:
- Publication type:
- Article
Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 7, p. 755, doi. 10.1002/jcph.2229
- By:
- Publication type:
- Article
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 695, doi. 10.1002/jcph.2208
- By:
- Publication type:
- Article
Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 486, doi. 10.1002/jcph.1978
- By:
- Publication type:
- Article
Need for Representation of Pediatric Patients with Obesity in Clinical Trials.
- Published in:
- Children, 2023, v. 10, n. 10, p. 1640, doi. 10.3390/children10101640
- By:
- Publication type:
- Article
Application of Solubility and Dissolution Profile Comparison for Prediction of Gastric pH-Mediated Drug-Drug Interactions.
- Published in:
- AAPS Journal, 2022, v. 24, n. 1, p. 1, doi. 10.1208/s12248-022-00684-3
- By:
- Publication type:
- Article
Exploring the Relationship of Drug BCS Classification, Food Effect, and Gastric pH-Dependent Drug Interactions.
- Published in:
- AAPS Journal, 2022, v. 24, n. 1, p. 1, doi. 10.1208/s12248-021-00667-w
- By:
- Publication type:
- Article
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 2046, doi. 10.1111/cts.13611
- By:
- Publication type:
- Article
Human radiolabeled mass balance studies supporting the FDA approval of new drugs.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2567, doi. 10.1111/cts.13403
- By:
- Publication type:
- Article
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2583, doi. 10.1111/cts.13362
- By:
- Publication type:
- Article
Fisetin Inhibits Cell Proliferation and Induces Apoptosis via JAK/STAT3 Signaling Pathways in Human Thyroid TPC 1 Cancer Cells.
- Published in:
- Biotechnology & Bioprocess Engineering, 2020, v. 25, n. 2, p. 197, doi. 10.1007/s12257-019-0326-9
- By:
- Publication type:
- Article
Promoting Clinical Trial Diversity: A Highlight of Select US FDA Initiatives.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 528, doi. 10.1002/cpt.2822
- By:
- Publication type:
- Article
The Importance of Diversity in Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 486, doi. 10.1002/cpt.2707
- By:
- Publication type:
- Article
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and Use.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 710, doi. 10.1002/cpt.1849
- By:
- Publication type:
- Article
An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 4, p. 841, doi. 10.1002/cpt.1473
- By:
- Publication type:
- Article
What Does It Take to Transform Real‐World Data Into Real‐World Evidence?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 10, doi. 10.1002/cpt.1486
- By:
- Publication type:
- Article
Real‐World Data and Clinical Pharmacology: A Regulatory Science Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 67, doi. 10.1002/cpt.1413
- By:
- Publication type:
- Article
Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 940, doi. 10.1002/cpt.1180
- By:
- Publication type:
- Article
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development.
- Published in:
- PLoS Computational Biology, 2018, v. 14, n. 12, p. 1, doi. 10.1371/journal.pcbi.1006614
- By:
- Publication type:
- Article
Crowdsourced Asparagus Urinary Odor Population Kinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 1, p. 34, doi. 10.1002/psp4.12264
- By:
- Publication type:
- Article
D-serine plasma concentration is a potential biomarker of ( R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.
- Published in:
- Psychopharmacology, 2015, v. 232, n. 2, p. 399, doi. 10.1007/s00213-014-3669-0
- By:
- Publication type:
- Article
Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 468, doi. 10.1111/cts.12945
- By:
- Publication type:
- Article
Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 6, p. 560, doi. 10.1111/cts.12675
- By:
- Publication type:
- Article
Unveiling the Genetic Architecture of Human Disease for Precision Medicine.
- Published in:
- 2019
- By:
- Publication type:
- Proceeding